Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fiona was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.

Horizontal portrait of Professor Fiona Powrie

Fiona Powrie, Professor of Musculoskeletal Sciences and Director of the Kennedy Institute, was announced this week as one of 26 newly elected international members to the National Academy of Sciences. Membership is a widely accepted mark of excellence in science and is considered one of the highest honours that a scientist can receive. In their announcement the Academy praised her outstanding contribution to immunology.

Fiona's research interests include characterisation of the interaction between the intestinal microbiota and the host immune system and how this mutualistic relationship breaks down in inflammatory bowel disease. Her work has identified the functional role of regulatory T cells in intestinal homeostasis and identified the cytokine IL-23 pathway as a therapeutic target in chronic intestinal inflammation.

"I did my postdoctoral training in the US and remain connected to the US immunology community," said Fiona. "I am deeply honoured to receive this recognition from them – it means a lot. Individual recognition like this always involves the work of many others. I am so grateful to the outstanding members of my lab and collaborators I have had the privilege to work with, funders particularly the Wellcome Trust and the University of Oxford for supporting my work."

Fiona is the third Professor from the Kennedy Institute to be elected, joining previous Kennedy Directors Professors Sir Marc Feldmann and Sir Ravinder (Tiny) Maini as a member of the Academy.

Professor Andy Carr commented: "I and the whole department extend our congratulations to Fiona on this prestigious award which recognises her huge contribution to global scientific discovery and to academic leadership."

The National Academy of Sciences is a private, nonprofit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863. It recognizes achievement in science by election to membership, and—with the National Academy of Engineering and the National Academy of Medicine—provides science, engineering, and health policy advice to the federal government and other organisations.

The 120 members and 26 international members elected this week bring the total number of active members to 2,403 and the total number of international members to 501.

Similar stories

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.